Ultrasonography and fine-needle aspiration cytology can spare breast cancer patients unnecessary sentinel lymph node biopsy

被引:165
作者
van Rijk, MC
Deurloo, EE
Nieweg, OE
Gilhuijs, KGA
Peterse, JL
Rutgers, EJT
Kröger, R
Kroon, BBR
机构
[1] Netherlands Canc Inst, Dept Surg, NL-1066 CX Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Dept Radiol, NL-1105 AZ Amsterdam, Netherlands
[3] Netherlands Canc Inst, Dept Radiol, NL-1066 CX Amsterdam, Netherlands
[4] Netherlands Canc Inst, Dept Pathol, NL-1066 CX Amsterdam, Netherlands
关键词
ultrasonography; mammary; breast neoplasms; lymphatic metastasis; sentinel lymph node biopsy;
D O I
10.1245/ASO.2005.01.024
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Some 30% to 40% of the breast cancer patients scheduled for sentinel node biopsy have axillary metastasis. Pilot studies suggest that ultrasonography is useful in the preoperative detection of such nodes. The aims of this study were to evaluate the sensitivity of preoperative ultrasonography and fine-needle aspiration cytology for detecting axillary metastases and to assess how often sentinel node biopsy could be avoided. Methods: Between October 1999 and December 2003, 726 patients with clinically negative lymph nodes were eligible for sentinel node biopsy. A total of 732 axillae were examined. Preoperative ultrasonography with subsequent fine-needle aspiration cytology in case of suspicious lymph nodes was performed in all patients. The sentinel node procedure was omitted in patients with tumor-positive axillary lymph nodes in lieu of axillary lymph node dissection. Results: Ultrasound and fine-needle aspiration cytology established axillary metastases in 58 (8%) of the 726 patients. These 58 were 21% of the total of 271 patients who were proven to have axillary metastasis in the end. Of the patients with ultrasonographically suspicious lymph nodes and negative cytology, 31% had tumor-positive sentinel nodes. Patients with preoperatively established metastases by ultrasonography and fine-needle aspiration cytology had more tumor-positive lymph nodes (P < .001) than patients with metastases established later on. Conclusions: The sensitivity of ultrasonography and fine-needle aspiration cytology is 21%, and unnecessary sentinel node biopsy is avoided in 8% of the patients. This approach improves the selection of patients eligible for sentinel node biopsy.
引用
收藏
页码:31 / 35
页数:5
相关论文
共 22 条
[1]   Impact of clinicopathological factors on sensitivity of axillary ultrasonography in the detection of axillary nodal metastases in patients with breast cancer [J].
Bedrosian, I ;
Bedi, D ;
Kuerer, HM ;
Fornage, BD ;
Harker, L ;
Ross, MI ;
Ames, FC ;
Krishnamurthy, S ;
Edeiken-Monroe, BS ;
Meric, F ;
Feig, BW ;
Akins, J ;
Singletary, E ;
Mirza, NQ ;
Hunt, KK .
ANNALS OF SURGICAL ONCOLOGY, 2003, 10 (09) :1025-1030
[2]  
Bland K.I., 2017, The breast: comprehensive management of benign and malignant disorders
[3]   Ultrasound-guided aspiration biopsy for detection of nonpalpable axillary node metastases in breast cancer patients: New diagnostic method [J].
Bonnema, J ;
vanGeel, AN ;
vanOoijen, B ;
Mali, SPM ;
Tjiam, SL ;
HenzenLogmans, SC ;
Schmitz, PIM ;
Wiggers, T .
WORLD JOURNAL OF SURGERY, 1997, 21 (03) :270-274
[4]  
Brenot-Rossi I, 2003, J NUCL MED, V44, P1232
[5]  
Camp ER, 2004, AM SURGEON, V70, P475
[6]   Analysis of fine needle aspiration cytology of the breast - A review of 1,297 cases and correlation with histologic diagnoses [J].
Choi, YD ;
Choi, YH ;
Lee, JH ;
Nam, JH ;
Juhng, SW ;
Choi, C .
ACTA CYTOLOGICA, 2004, 48 (06) :801-806
[7]  
CUTLER SJ, 1969, CANCER, V23, P767, DOI 10.1002/1097-0142(196904)23:4<767::AID-CNCR2820230404>3.0.CO
[8]  
2-V
[9]   Multicentre study of ultrasonographically guided axillary node biopsy in patients with breast cancer [J].
de Kanter, AY ;
van Eijck, CHJ ;
van Geel, AN ;
Kruijt, RH ;
Henzen, SC ;
Paul, MA ;
Eggermont, AMM ;
Wiggers, T .
BRITISH JOURNAL OF SURGERY, 1999, 86 (11) :1459-1462
[10]   Reduction in the number of sentinel lymph node procedures by preoperative ultrasonography of the axilla in breast cancer [J].
Deurloo, EE ;
Tanis, PJ ;
Gilhuijs, KGA ;
Muller, SH ;
Kröger, R ;
Peterse, JL ;
Rutgers, EJT ;
Olmos, RV ;
Kool, LJS .
EUROPEAN JOURNAL OF CANCER, 2003, 39 (08) :1068-1073